ACAD
ACADIA PHARMACEUTICALS INC- Last price
- $21.68
- As of
Active signals for ACAD
- mediumEARNINGS_MISS
Missed consensus by 68.4% — EPS $0.02 vs $0.0633 estimate
- mediumEARNINGS_BEAT
Beat consensus by 1044.5% — EPS $1.6 vs $0.1398 estimate
- mediumEARNINGS_BEAT
Beat consensus by 178.1% — EPS $0.42 vs $0.151 estimate
- mediumEARNINGS_BEAT
Beat consensus by 14.4% — EPS $0.16 vs $0.1398 estimate
- mediumEARNINGS_BEAT
Beat consensus by 178.1% — EPS $0.42 vs $0.151 estimate
Top institutional holders of ACAD (13F)
| Fund | Market value | % portfolio | QoQ |
|---|---|---|---|
| Point72 Asset Management, L.P. | $90.2M | 0.10% | +127.2% |
| RENAISSANCE TECHNOLOGIES LLC | $40.9M | 0.06% | +5.7% |
| RENAISSANCE TECHNOLOGIES LLC | $38.4M | 0.06% | +12.5% |
| Point72 Asset Management, L.P. | $31.7M | 0.05% | , |
| RENAISSANCE TECHNOLOGIES LLC | $30.9M | 0.04% | , |
| TWO SIGMA INVESTMENTS, LP | $29.9M | 0.04% | +68.1% |
| D. E. Shaw & Co., Inc. | $27.4M | 0.01% | -14.8% |
| D. E. Shaw & Co., Inc. | $25.7M | 0.01% | , |
| TWO SIGMA INVESTMENTS, LP | $17.3M | 0.01% | -30.7% |
| D. E. Shaw & Co., Inc. | $16.2M | 0.01% | -28.9% |
| TWO SIGMA INVESTMENTS, LP | $14.2M | 0.02% | , |
| Bridgewater Associates, LP | $3.7M | 0.01% | -15.4% |
| Bridgewater Associates, LP | $3.5M | 0.01% | , |
| Bridgewater Associates, LP | $3.2M | 0.01% | +2.6% |
| CITADEL ADVISORS LLC | $2M | 0.00% | , |
| CITADEL ADVISORS LLC | $694K | 0.00% | -72.2% |
| Point72 Asset Management, L.P. | $305K | 0.00% | -99.6% |
Sourced from quarterly 13F filings with the U.S. Securities and Exchange Commission.
Recent SEC filings, ACAD
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
See more ACAD signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Sign in to track ACAD in your watchlist and get notified the moment a new signal fires.
Track ACAD on Kresmion →